This is a recording from Portland Psychedelic Conference 2018
01:33:19 min
CLEAR ALL
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.
1
Drugs like LSD and MDMA are generating new interest among doctors for use in psychotherapy.
Interview with Rick Doblin, Ph.D. Founder of psychedelic research group MAPS, as he talks about his experience with Ibogaine and LSD, in order to confront his own shadows and be more effective as a political activist.
Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising.
Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.